TD Reiterates C$8.50 Price Target for WELL Health Technologies (TSE:WELL)

WELL Health Technologies (TSE:WELL) has been given a C$8.50 target price by equities researchers at TD in a research note issued on Monday, BayStreet reports. The firm presently has a “buy” rating on the stock. TD’s price objective suggests a potential upside of 90.16% from the stock’s previous close.

Separately, Canaccord Genuity Group lifted their price objective on WELL Health Technologies from C$6.50 to C$7.75 and gave the stock a “buy” rating in a report on Thursday, July 9th. Five investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of C$7.40.

WELL Health Technologies Price Performance

WELL stock traded up C$0.16 during midday trading on Monday, reaching C$4.47. The company had a trading volume of 1,013,915 shares, compared to its average volume of 1,367,758. WELL Health Technologies has a 1 year low of C$3.58 and a 1 year high of C$6.08. The firm has a 50-day moving average price of C$4.25 and a 200-day moving average price of C$4.21. The company has a market capitalization of C$1.14 billion, a P/E ratio of 223.50, a P/E/G ratio of -1.93 and a beta of 0.71. The company has a debt-to-equity ratio of 100.05, a current ratio of 0.80 and a quick ratio of 1.02.

WELL Health Technologies (TSE:WELL) last released its earnings results on Thursday, August 6th. The company reported C$0.04 EPS for the quarter. WELL Health Technologies had a return on equity of 0.44% and a net margin of 0.25%.The business had revenue of C$400.43 million for the quarter. On average, research analysts anticipate that WELL Health Technologies will post 0.3000698 earnings per share for the current fiscal year.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. (TSX: WELL) is Canada’s largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.